Matinas BioPharma Completes Private Placement of $8.0 Million
BEDMINSTER, N.J., Sept. 13, 2016 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (“Matinas BioPharma” or the “Company”) (OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective broad spectrum …